"Abstract: Two mRNA-based COVID injectables were granted emergency use authorization in both children and adults in 2021 after an accelerated approval process that allowed the manufacturers to fast-track their products. We analyzed data from regulatory surveillance and self-reporting systems such as Defense Medical Epidemiology Database(DMED); EudraVigilance; Eurostat; German health insurers; the Israeli Ministry of Health; the Natural Cycles App; Public Health Scotland; the United Kingdom’s (UK) Office for National Statistics (ONS); UK’s yellow card reporting system; the Vaccine Adverse Event Reporting System (VAERS); and V-Safe After Vaccination Health Checker entries to find long-term adverse events of the COVID products that cannot be captured during the expedited safety analyses... Our data show, among other trends, increases in adverse event reports if we compare COVID products to influenza and pertussis vaccines and statistically significant higher numbers of hospital encounters in military personnel, as well as increases in incidences of thromboembolic conditions, such as menstrual abnormalities, myocarditis, and cerebrovascular events after the implementation of COVID injection mandates, compared to the preceding five years."
If material is quoted or reprinted, users are asked to give credit to the source/author, and to conform to the non-commercial, no derivatives, requirements of the Creative Commons License 4.0 NC ND or to any other license that takes precedence over it.